Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:653-654 (23 September), doi:10.1136/bmj.333.7569.653-b
EDITORMathew et al describe some of the risk factors and consequences of contrast induced nephropathy, a condition increasingly encountered after elective and emergency cardiac angiography and angioplasty.1 The role of N-acetylcysteine in preventing this common condition is often underemphasised. Many good prospective randomised controlled trials support its use, as do most meta-analyses, but the strength of overall conclusions is often hindered by the heterogeneity of the study protocols of the included trials. A dose dependent relation with both oral and intravenous administration has clearly shown a reduction of contrast induced nephropathy in patients undergoing cardiac angiography.2 3
Pre-hydration is simple, cheap, carries minimal risk, and should be routinely used despite the lack of a large prospective randomised controlled trial of hydration versus no hydration. Correction of subclinical dehydration may be the principal benefit. However, the route and type of fluid prescribed seem to be important in preventing contrast induced nephropathy. Intravenous isotonic fluid (0.9% saline) is more effective than half isotonic fluid (0.45% saline),4 and intravenous administration is more effective than oral.5 Most benefit is seen in high risk groups.
Amit Patel, senior house officer in cardiology
Heart Hospital, London W1G 8PH amit.patel{at}doctors.org.uk
What can you learn from this BMJ paper? Read Leanne Tite's Paper+